A form of preventative genetic testing is now available in 42 new countries through the geneType™ Risk Assessment portfolio, which can be accessed through Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF)'s EasyDNA platform.
Join Proactive’s Tylah Tully for this episode of Just The Facts as she explores the GTG’s new market for genetic testing services, which promise early disease prediction and enables personalised preventative healthcare plans geared to manage each individual’s risks.
“We are executing on our vision and strategy to be a leader in personalised predictive genomics,” CEO Simon Morris said in an investor webinar.
"Our journey from R&D and innovation to commercialisation and profitability is well underway.”